Aptose Biosciences APTO

$ 0.28 0.7%

Quarterly report 2024-Q2
added 08-08-2024

Aptose Biosciences Income Statement 2011-2024 | APTO

Annual Income Statement Aptose Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	10.8 M	9.84 M	89.1 M	337 M	347 M	68.5 M	67.6 M	-	35 M	29.4 M	8.87 M	9.32 M	9.21 M
Shares	6.76 M	6.15 M	89.1 M	81.8 M	50.2 M	33.4 M	22.3 M	-	11.9 M	5.22 M	3.52 M	1.69 M	1.1 M
Historical Prices	1.6	1.6	1.2	3.96	8.01	1.76	2.79	1.14	2.77	4.97	8.64	2.76	2.4
Net Income	-12 M	-10 M	-65.4 M	-55.2 M	-26.3 M	-28.9 M	-11.7 M	-13.9 M	-10.5 M	-9.73 M	-5.4 M	-4.48 M	-5.16 M
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	88 K	120 K	150 K	-55.2 M	-26.7 M	-29 M	-11.7 M	-13.7 M	-11.3 M	-8.77 M	-5.36 M	-4.42 M	-5.04 M
Operating Expenses	52.4 M	42.6 M	65.4 M	55.8 M	26.9 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	15.6 M	14.5 M	19.5 M	26.3 M	9.9 M	10.3 M	5.5 M	6.13 M	7.05 M	6.07 M	2.2 M	2.14 M	2.69 M

All numbers in USD currency

Quarterly Income Statement Aptose Biosciences

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	16.8 M	13.1 M	7.94 M	6.5 M	6.23 M	6.17 M	6.16 M	6.15 M	6.15 M	92.2 M	92.2 M	88.9 M	88.9 M	88.9 M	88.9 M	85.9 M	76.3 M	76.2 M	76.1 M	55.5 M	46.5 M	39.8 M	38.2 M	34.6 M	34 M	29 M	27.5 M	24.1 M	21.3 M	17.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-7.25 M	-9.64 M	-	-11.4 M	-14.1 M	-13.7 M	-	-9.78 M	-10.6 M	-11.5 M	-24.3 M	-11.3 M	-13.5 M	-16.2 M	-14.7 M	-13.2 M	-15.8 M	-11.5 M	-7.71 M	-6.84 M	-6.22 M	-5.51 M	-6.26 M	-5.53 M	-10.3 M	-6.81 M	-3.27 M	-2.64 M	-2.44 M	-3.29 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	8 K	16 K	-	20 K	22 K	28 K	-	30 K	30 K	32 K	-	36 K	35 K	35 K	-	37 K	37 K	41 K	-	33 K	53 K	29 K	-	29 K	19 K	16 K	-	20 K	23 K	23 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	7.34 M	9.76 M	-	11.7 M	14.5 M	14.1 M	-	10 M	10.7 M	11.5 M	-	11.4 M	13.5 M	16.3 M	-	13.3 M	15.9 M	11.8 M	-	7.03 M	6.35 M	5.6 M	-	5.61 M	10.3 M	6.84 M	-	2.71 M	2.48 M	3.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.93 M	3.32 M	-	3.42 M	3.87 M	5.28 M	-	3.45 M	3.33 M	4.11 M	-	3.64 M	3.66 M	8.02 M	-	5.78 M	9.02 M	5.9 M	-	2.28 M	2.86 M	2.26 M	-	2.02 M	2.51 M	3.7 M	-	1.32 M	1.39 M	1.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency